Impact Of Pelvic Lymphadenectomy On Disease-Free Survival After Radical Prostatectomy: A Multicenter Study
Main Category: Urology / NephrologyAlso Included In: Prostate / Prostate Cancer; Clinical Trials / Drug Trials
Article Date: 25 May 2008 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
UroToday.com - Extended pelvic lymphadenectomy (PLND) increases the yield of both total and positive lymph nodes (LN). Studies have also demonstrated that up to 40% of all LN metastasis are localized outside the region of the standard obturator and external iliac PLND. The aim of this study was to analyze the impact of PLND on PSA failure (PSAF).
The researchers retrospectively analyzed the databases of radical prostatectomies (RP) from three different Urological Departments. Center A performed only perineal prosatectomies (PP) with no PLND in patients with PSA <10ng/ml. The two others performed retropubic prostatectomy in all patients. Center B performed a standard PNLD and center C an extended PLND including internal and common iliac LN.
They performed a first analysis on 2,380 patients from the 3 cohorts with a PSA <10ng/ml and cT<3: 688, 889, and 803 from groups A, B and C respectively. Baseline demographic and pathological characteristics were different for the three cohorts with group C having higher risk patients. The median of LN removed was 0, 6 and 14 and LN+ 0%, 1.2% and 6% respectively. Cox regression multivariate analysis identified pre-operative PSA, p-stage, positive margins, pathologic Gleason score, neo- and adjuvant therapy as significant risk factors of PSAF all at p<0.0001. While adjusting for these variables the risk of PSAF was increased in patients with PP and no PLND (Group A) vs. extended PLND (Group C) but not vs. standard PLND (Group B). When analyzing the pN0 vs. pNx patients of PP in multivariate analysis, standard vs. no PLND did not reduce the risk of PSAF while extended POLND was associated with a risk reduction of 64%. They then compared the two complete cohorts B and C comprising 1,900 patients using Cox-regression multivariate analysis. Standard PLND was associated with 2 times more risk of PSAF (HR 2.11 p<.0001) compared to extended PLND. Type of PLND was a stronger independent predictor than p-Stage, Gleason >7 and positive margin.
This data suggests that the extent of PLND and particularly removal of internal iliac and common iliac nodes can reduce the risk of biochemical recurrence after RP.
Presented by Michele Lodde, MD, Helene Hovington, MD, Francois Harel, MD, Michael J Harris, MD, David P Wood, MD, Michel Hugues Lebel, MD, Luis Lacombe, MD, Yves Fradet, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our urology / nephrology section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/108713.php>
APA
http://www.medicalnewstoday.com/releases/108713.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



